CytoTronics’ Pixel System Receives 2024 R&D 100 Award

Boston, MA – August 27, 2024 – CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, is pleased to announce their flagship product, Pixel™, has been honored with a 2024 R&D 100 Award. Pixel’s innovative semiconductor-to-live-cell interface empowers cell biologists to re-imagine their experiments and unlock new applications that haven’t been possible before. Early adopters around the world are harnessing Pixel in therapeutic areas including vascular, inflammatory, cardiovascular, and neurological disease, rare disease, and oncology.

By enabling thousands of simultaneous, multi-modal readouts on any cell type at single-cell resolution, Pixel dramatically accelerates the scale at which cell biology applications can be executed, and the breadth and depth of live-cell insights obtained. Recognized in the Analytical/Test category of the R&D 100 Awards, this first-of its-kind system lets scientists assess live cell function with simultaneous monitoring of cell viability, morphology, electrophysiology, metabolism, and more while generating non-invasive electrical images with single-cell spatial resolution — for the first time.

“We envision Pixel becoming an essential tool in every lab, revolutionizing drug discovery and biomedical research. Our pioneering advancements in semiconductor-bio interface design mark a significant engineering and scientific achievement,” said Vince Wu, Ph.D., co-founder and CTO of CytoTronics. “Receiving the prestigious R&D 100 Award acknowledges Pixel is poised to transform cell biology discovery as we know it.”

Since 1963, the R&D 100 Awards program has identified and celebrated the top 100 revolutionary technologies of the past year, and is the only science and technology awards competition that recognizes new commercial products, technologies, and materials for their technological significance that are available for sale or license. This renowned worldwide science and innovation competition, sponsored by R&D World Magazine, is now in its 62nd year. The 2024 esteemed judging panel included 56 well-respected industry professionals from across the world.

To learn more about Pixel or enroll in the early access program, visit www.cytotronics.com or follow us on LinkedIn. To get some hands-on time with Pixel, stop by the CytoTronics booth at Biomolecular Imaging and Informatics in Boston September 18-20, the MSD Technology Symposium in Philadelphia September 24-25, Neuroscience in Chicago October 5-9, or Cell Bio in California December 14-18.